Pembrolizumab-Induced Sclerosing Cholangitis.

Tahboub Amawi, Ali Dean; Tremaine, William J; Venkatesh, Sudhakar K

Tahboub Amawi, Ali Dean; Tremaine, William J; Venkatesh, Sudhakar K.

Affiliation

Tahboub Amawi AD; Division of Abdominal Imaging, Department of Radiology, Mayo Clinic, Rochester, Minnesota.
Tremaine WJ; Division of Gastroenterology and Hepatology, Department of Medicine, Mayo Clinic, Rochester, Minnesota.
Venkatesh SK; Division of Abdominal Imaging, Department of Radiology, Mayo Clinic, Rochester, Minnesota.

Clin Gastroenterol Hepatol ; 20(2): e18, 2022 02.

Article in En | MEDLINE | ID: mdl-33279784

Subject(s)

Cholangitis, Sclerosing; Antibodies, Monoclonal, Humanized/adverse effects; Cholangitis, Sclerosing/chemically induced; Humans

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cholangitis, Sclerosing Limits: Humans Language: En Journal: Clin Gastroenterol Hepatol Journal subject: GASTROENTEROLOGIA Year: 2022 Type: Article

Fulltext

XML

PubMed Links

Search on Google